Search - tctmd.com

Displaying 141 - 160 of 825

Sort: Relevancy | Date

News Daily News

Hypertension Expert George Bakris Mourned by Colleagues and Friends

L.A. McKeown

June 18, 2024

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

L.A. McKeown

June 11, 2024

News Daily News

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Yael L. Maxwell

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

L.A. McKeown

May 24, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

Caitlin E. Cox

May 08, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Todd Neale

April 12, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

Advertisement

Hypertension Expert George Bakris Mourned by Colleagues and Friends

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

How Mediterranean Diets Might Cut Mortality in Women: New Insights

June 2024 Dispatch for the CV Team

FLOW: Semaglutide Scores Big in Diabetic Patients With CKD

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Atherosclerosis Progression May Share Traits With Tumor Growth

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

May 2024 Dispatch for the CV Team

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

TCTMD’s Top 10 Most Popular Stories for March 2024

April 2024 Dispatch for the CV Team

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content